Listed

CVS HEALTH Corp

CVSNYSECIK 64803Consumer staplesFiscal year ends Dec 31

Reports and events: 372 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

CVS HEALTH Corp, Reports and events
FiledFormWhat it isAccession number
2018-02-0806:56 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000064803-18-000012
2018-02-0617:39 ET8-K5.02 Departure or appointment of officers or directors0000064803-18-000007
2018-02-0117:20 ET8-K8.01 Other events0001193125-18-029474
2018-01-0407:14 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-18-002185
2017-12-1917:22 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-17-373753
2017-12-0517:33 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-17-361800
2017-12-0407:52 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-359526
2017-11-0616:50 ET10-QQuarterly reportPeriod 2017-09-300001558370-17-008250
2017-11-0606:56 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000064803-17-000032
2017-08-0807:16 ET10-QQuarterly reportPeriod 2017-06-300001558370-17-006198
2017-08-0806:56 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-17-006194
2017-05-1216:45 ET8-K5.07 Shareholder vote results0001193125-17-168702
2017-05-0216:07 ET10-QQuarterly reportPeriod 2017-03-310001558370-17-003258
2017-05-0207:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-17-003216
2017-03-3116:16 ETDEF 14AProxy statementPeriod 2017-05-100001206774-17-001033
2017-03-0217:01 ET8-K9.01 Financial statements and exhibits0000064803-17-000008
2017-02-0916:03 ET10-KAnnual reportPeriod 2016-12-310000064803-17-000006
2017-02-0906:57 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000064803-17-000004
2016-12-1507:36 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000064803-16-000104
2016-11-0809:34 ET8-K/A2.02 Results of operations; 9.01 Financial statements and exhibits0000064803-16-000099
2016-11-0807:00 ET10-QQuarterly reportPeriod 2016-09-300000064803-16-000097
2016-11-0806:57 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000064803-16-000096
2016-08-0216:41 ET10-QQuarterly reportPeriod 2016-06-300000064803-16-000090
2016-08-0207:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000064803-16-000088
2016-06-1416:44 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-621362
2016-06-0216:37 ET8-K8.01 Other events0000064803-16-000084
2016-05-3108:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-607314
2016-05-2517:11 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-602417
2016-05-2016:37 ET8-K5.07 Shareholder vote results0000064803-16-000082
2016-05-1816:42 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-594552
2016-05-1608:55 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-591252
2016-05-0316:48 ET10-QQuarterly reportPeriod 2016-03-310000064803-16-000080
2016-05-0309:02 ET8-K/A2.02 Results of operations; 9.01 Financial statements and exhibits0000064803-16-000078
2016-05-0306:59 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000064803-16-000076
2016-04-0809:28 ETDEF 14AProxy statementPeriod 2016-05-190001206774-16-005376
2016-02-0916:29 ET10-KAnnual reportPeriod 2015-12-310000064803-16-000074
2016-02-0906:57 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000064803-16-000072
2016-01-2616:47 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0000064803-16-000070
2015-12-1607:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000064803-15-000066
2015-10-3016:50 ET10-QQuarterly reportPeriod 2015-09-300000064803-15-000064
2015-10-3007:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000064803-15-000062
2015-10-1417:12 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-15-343838
2015-09-2216:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000064803-15-000060
2015-08-1816:46 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0000064803-15-000058
2015-08-0517:36 ETDEF 14AProxy statementPeriod 2015-08-040000064803-15-000056
2015-08-0416:54 ET10-QQuarterly reportPeriod 2015-06-300000064803-15-000054
2015-08-0407:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000064803-15-000051
2015-07-2013:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-15-256793
2015-07-1716:48 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-15-256071
2015-06-1507:06 ET8-K7.01 Regulation FD disclosure0000064803-15-000036

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.